Home | GSK US
WEBSeptember 16 2024 Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk. September 11 2024 Statement: Zantac (ranitidine) litigation – Dixon case. September 06 2024 GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD. View all press releases.
GSK plc - Wikipedia
WEBGSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Home | GSK
WEBOur purpose. We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Company | GSK US
WEBGSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
Products - GSK US
WEBProducts. Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States.
Company | GSK
WEBWe are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
WEBFind the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK and CureVac to develop next generation mRNA COVID-19 …
WEBGSK will also support manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine CVnCoV in 2021. GlaxoSmithKline plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) today announced a new €150m collaboration, building on their existing relationship, to jointly develop next …
GSK announces positive topline data on co-administration of …
WEB4 days ago · The Control group received GSK’s RSV vaccine at day 31. 1,2 RZV second dose was administered at day 61 for both groups. 1,2 The primary endpoint was the non-inferiority of the humoral immune responses to GSK’s RSV vaccine and RZV when co-administered compared to when administered at separate visits. 1,2 Key secondary endpoints included ...
GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve …
WEBJul 2, 2012 · Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice ...